ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1391	National Cancer Institute	Html	en	Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of Wilms tumor.	wilms tumors 0.503727 wilms tumor 0.905843 Wilms tumor development 0.5254 Wilms tumor genetics 0.517912 Wilms Tumor Study-5 0.477443 familial Wilms tumour 0.446601 favorable-histology wilms tumor 0.511105 stage II Wilms 0.439212 unilateral Wilms tumor 0.553115 Wilms tumor patients 0.529584 favorable histology Wilms 0.460427 bilateral Wilms patients 0.460054 Tumor Study Group 0.595101 contralateral Wilms tumor 0.495745 Wilms tumor-Aniridia syndrome 0.439108 preoperative wilms tumor 0.505524 bilateral wilms tumor 0.635902 stromal-type Wilms tumor 0.516983 Wilms tumor surveillance 0.49553 beckwith-wiedemann syndrome 0.43423 inoperable Wilms tumor 0.526248 Group/National Wilms Tumor 0.47873 Low-risk Wilms Tumor 0.474612 histology Wilms tumors 0.433526 Wilms Tumor Study 0.723902	Wilms tumor screening 0.479856 wilms tumor rupture 0.501052 et al. 0.499553 wilms tumor predisposition 0.521351 histology Wilms tumor 0.504567 Wilms tumours 0.453209 COG Wilms tumor 0.518219 SIOP Wilms Tumor 0.504401 Wilms tumour 0.50015 bilateral Wilms tumor. 0.45063 Pediatr Blood Cancer 0.440629 wilms tumor suppressor 0.492641 nonsyndromic Wilms tumor 0.493832 Metachronous bilateral Wilms 0.434751 National Wilms Tumor 0.736085 Med Genet 0.447601 Abstract 0.531043 Clin Oncol 0.453706 familial Wilms tumor. 0.444435 Wilms tumor locus 0.521817 Familial Wilms tumor 0.495658 non-WT1-syndromic Wilms tumor 0.488494 Wilms Tumor Study-3 0.478135 Wilms tumor susceptibility 0.497583	CLICK HERE
1413	National Cancer Institute	Html	en	Delirium (PDQ®)–Patient Version	Expert-reviewed information summary about delirium as a complication of cancer or its treatment. Supportive care and pharmacologic approaches to the management of delirium are discussed.	delirium symptoms 0.709857 nitrogen waste products 0.577723 PDQ cancer information 0.770129 health care team 0.586883 clinical trial search 0.576381 white blood cells 0.577889 clinical trials 0.698332 health care providers 0.640731 cancer information summary 0.69366 health care professionals 0.630449 clinical trial 0.629959 family members 0.626279 breast cancer prevention 0.590247 risk factors 0.581853 PDQ summaries 0.586791 patients 0.70258 cancer patients 0.599627 latest published information 0.583983 NCI’s PDQ 0.59158 NCI PDQ cancer 0.638613 medical conditions 0.583938 mental state 0.591128 treatment 0.629672 medicines 0.581999	cancer prevention 0.590786 Cancer Information Service 0.600573 PDQ Supportive 0.581242 patient 0.833691 treatment clinical trials 0.58693 National Cancer Institute 0.701492 PDQ documents 0.58189 delirium 0.950204 health care 0.718989 Palliative Care Editorial 0.637171 new treatment 0.588734 Cancer Care page 0.597168 PDQ database 0.584618 patient changes 0.579334 Care Editorial Board 0.639637 risk factor 0.616509 PDQ summary 0.609325 cancer clinical trials 0.602276 cancer information summaries 0.605913 health professional versions 0.578381 comprehensive cancer information 0.605614 cancer patient 0.595386 Older patients 0.584199 cancer 0.788674	CLICK HERE
1449	National Cancer Institute	Html	en	Chronic Myelogenous Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of chronic myelogenous leukemia.	imatinib arm. 0.510874 imatinib treatment 0.498472 BCR/ABL tyrosine kinase. 0.475402 chronic phase 0.568994 selective imatinib intensification 0.531551 chronic-phase CML 0.475324 Kantarjian HM 0.499766 standard-dose imatinib therapy 0.507991 myeloid leukemia patients 0.529265 optimized high-dose imatinib 0.503652 imatinib dose escalation 0.504714 chronic myeloid leukemia 0.974854 myelogenous leukemia patients 0.471866 first-line imatinib 0.514414 newly diagnosed patients 0.526185 CML 0.506893 patients 0.710768 imatinib 0.732822 chronic myelogenous leukemia 0.688539 molecular response 0.621232 blast crisis 0.504661 complete cytogenetic response 0.48751 high-dose imatinib 0.517116 previous tyrosine kinase 0.510969 complete cytogenetic responses 0.473533	tyrosine kinase inhibitor 0.619296 BCR/ABL tyrosine kinase 0.479945 et al. 0.49902 Treatment-Naïve Chronic Myeloid 0.474051 Imatinib plasma trough 0.531841 tyrosine kinase 0.812535 imatinib group 0.503477 allogeneic bone marrow 0.520192 newer tyrosine kinase 0.511438 imatinib mesylate 0.627198 Dasatinib Versus Imatinib 0.532218 more-potent tyrosine kinase 0.486098 bone marrow transplantation 0.522565 tyrosine kinase inhibitors 0.801096 10-year follow-up period 0.488853 front-line imatinib 0.512448 daily imatinib mesylate 0.512872 major molecular response 0.597118 Abstract 0.523832 Clin Oncol 0.565656 imatinib mesylate treatment 0.521115 bone marrow 0.522631 chronic myeloid leukaemia 0.4741 imatinib era 0.488593	CLICK HERE
1528	National Cancer Institute	Html	en	Ovarian Low Malignant Potential Tumors Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.	currently used treatment 0.491433 treatment 0.80031 abnormal cells 0.591776 cancer treatment 0.491469 ovaries 0.553108 abdomen 0.566902 body cavity 0.495458 NCI-supported cancer 0.497228 tissue 0.516419 cancer cells 0.493195 body 0.515176 Cancer Information Service 0.489344 low malignant potential 0.507879 PDQ cancer information 0.620272 clinical trial search 0.566415 uterus 0.498028 treatment clinical trials 0.555055 National Cancer Institute 0.572253 clinical trials 0.964888 tumor cells 0.695966 Treatment Options section 0.484079 cancer information summary 0.567078 clinical trial 0.741404 new treatment 0.564234	disease 0.554973 malignant potential tumor 0.900634 new treatments 0.489278 patients 0.603036 earlier clinical trials 0.497766 clinical trials database 0.496798 peritoneal cavity 0.517264 Potential Tumors Treatment 0.491558 treatment clinical trial 0.511947 PDQ Adult Treatment 0.504736 NCI PDQ cancer 0.507801 ovary 0.536161 cancer clinical trials 0.578107 tests 0.498811 stage 0.7416 malignant potential tumors 0.621847 fallopian tubes 0.57444 treatment options 0.549139 Treatment Editorial Board 0.533517 cancer information summaries 0.487894 comprehensive cancer information 0.488381 cancer 0.721628 standard treatment 0.552748	CLICK HERE
1712	National Cancer Institute	Html	en	Antioxidants and Cancer Prevention	A fact sheet about antioxidants, substances that may protect cells from the damage caused by unstable molecules known as free radicals. Free radical damage may lead to cancer.	Nutrition Intervention Trial 0.501895 esophageal cancer 0.494202 cancer prevention 0.637226 dietary antioxidant supplements 0.628093 Retinol Efficacy Trial 0.539912 antioxidants 0.567107 supplementation 0.636543 beta-carotene supplementation 0.609246 vitamin E supplementation 0.519408 randomized controlled trials 0.504401 trial 0.573618 daily supplementation 0.567334 lung cancer 0.591669 Alpha-Tocopherol/Beta-Carotene Cancer Prevention 0.499391 Health Study 0.544001 free radical damage 0.506138 beta-carotene supplements 0.507967 National Cancer Institute 0.710208 dietary antioxidants 0.513132 beta carotene 0.496454 cardiovascular disease 0.651531 Cancer Prevention Study 0.537001 Vitamin E Cancer 0.510878	free radicals 0.842716 exogenous antioxidants 0.527581 Cancer Prevention Trial 0.559457 alpha-tocopherol supplementation 0.518828 gastric cancer 0.506898 skin cancer incidence 0.521176 antioxidant vitamins 0.499147 cancer development 0.495835 total cancer incidence 0.520828 randomized controlled trial 0.509347 antioxidant supplementation 0.554893 antioxidant supplements 0.754474 prostate cancer 0.575846 effects 0.540142 all-cause mortality 0.510888 et al 0.922404 New England Journal 0.537799 cancer risk 0.507337 lung cancer incidence 0.528817 cancer 0.94983 incidence 0.572134 cancer incidence 0.567041 long-term beta-carotene supplementation 0.539474	CLICK HERE
1796	National Cancer Institute	Html	es	Depresión (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del diagnóstico, evaluación y tratamiento de la depresión en adultos y niños que padecen de cáncer.	PDQ Adaptación 0.900589 pequeño número 0.729693 querido enfermo 0.783448 siguientes aspectos 0.842073 Physician Data Query 0.803023 antidepresivos quizás 0.773298 salud mental 0.794578 suficiente apoyo 0.736237 siguientes razones 0.808967 sustancias químicas ayuda 0.796554 Anfotericina B 0.785281 médico hará preguntas 0.761623	único irdn 0.752807 Red Nacional 0.736951 niños quizás 0.74099 efectos tardíos 0.735838 busque ayuda 0.740646 National Cancer Institute 0.721502 siguientes riesgos 0.72378 siguientes pruebas 0.814768 PDQ Depresión 0.788745 siguientes temas 0.821536 Instituto Nacional 0.830302	CLICK HERE
1867	National Cancer Institute	Html	es	Tratamiento del cáncer de seno paranasal y de cavidad nasal (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de seno paranasal y de cavidad nasal.	Lippincott Williams 0.142692 Wynstra JH 0.159843 Sterman BM 0.185832 Neck Cancer Cooperative 0.146574 Pilepich MV 0.159353 Solero CL 0.185478 seno etmoides 0.29943 necesarias radioterapia 0.151326 Pfister DG 0.146109 malignant tumors 0.232702 paranasal sinus 0.195953 Arch Otolaryngol Head 0.468056 Radiat Oncol Biol 0.619431 DeVita VT Jr 0.178945 Anterior craniofacial resection 0.258045 Shah JP 0.184681 Levine HL 0.185883 Rosenberg SA 0.139862 placas pterigoides 0.137887 radiation therapy 0.436289 Head Neck Surg 0.553355 Factors influencing 0.192749 Neck Tumors 0.161157 Lawrence TS 0.140398 Mendenhall WM 0.145915	Head Neck 0.837692 nasal vestibule 0.268686 radioterapia postoperatoria 0.19834 paranasal sinus tumors 0.157406 radioterapia posoperatoria 0.262078 Otolaryngol Head Neck 0.541214 craniofacial resection 0.26625 Mariani L 0.182178 Cantù G 0.181147 PDQ Tratamiento 0.251079 Hawkins RB 0.160122 9th ed 0.144765 Kraus DH 0.187503 nasal cavity 0.24641 Werning JW 0.146295 Oncol Biol Phys 0.641171 cánceres nasofaríngeos 0.195804 skull base 0.209046 sección cáncer 0.172955 Acta Otorhinolaryngol Belg 0.258981 neck cancer 0.879092 Acta Oncol 0.146983 adjuvant radiotherapy 0.160643 haz externo 0.195232	CLICK HERE
1898	National Cancer Institute	Html	es	Tratamiento del cáncer de recto (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de recto.	pequeña porción 0.344303 siguientes procedimientos 0.488361 estadio iv 0.798609 siguientes aspectos 0.39574 ecografía transrectal 0.363875 siguientes tipos 0.371556 tumor causa obstrucción 0.365452 rayos x 0.358514 estadio ivb 0.576844 enlace drugs approved 0.373438 menor cantidad 0.340782 escáner tep 0.363457 ondas sonoras 0.360161 estadio iva 0.572549 información ayuda 0.344729 recto forma 0.870609 quimioterapia sistémica 0.542487 proteína llamada factor 0.366746 National Cancer Institute 0.340908 recto recidivante 0.833054	cáncer.ampliar colonoscopia 0.503991 Instituto Nacional 0.373842 estadio iiia 0.782206 PDQ Tratamiento 0.378717 antecedentes familiares 0.362005 estadio iiic 0.75767 estadio iiib 0.767428 estadio iia 0.790435 siguientes problemas 0.397252 estadio iic 0.78747 células cancerosas.El bevacizumab 0.411094 Physician Data Query 0.44928 Malestar abdominal 0.370918 Rectal Cancer 0.347301 crecer.El ziv-aflibercept 0.34268 antígeno carcinoembrionario 0.591724 sección cáncer 0.945618 ano).ampliar extirpación 0.350725 siguientes sumarios 0.436031 siguientes pruebas 0.396087	CLICK HERE
3457	National Cancer Institute	Html	es	Aromaterapia y aceites esenciales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del uso de la aromaterapia y los aceites esenciales para mejorar la calidad de vida de los pacientes de cáncer.	Aromaterapia Holística 0.562365 células madre 0.538543 Centro Nacional 0.523442 cuidado médico 0.513326 New Hampshire Avenue 0.516719 Edad Media 0.513057 Drug Administration 0.51036 materiales básicos 0.513447 NCI Best Case 0.529134 Asociación Nacional 0.510623 International Aromatherapists 0.5134 datos bibliográficos pubmed 0.517834 efectos calmantes 0.525108 índices respiratorios 0.51441 Canadian Federation 0.513125 National Cancer Institute 0.519273 aromaterapia mejora 0.571233 siguientes riesgos 0.511793 frecuencia respiratoria 0.513664 Instituto Nacional 0.589131 acupuntura ayuda 0.509756 antigua china 0.513893	Salud Complementaria 0.537165 Visuals Online 0.511883 complementarias revisa 0.516354 Federación Canadiense 0.511817 Physician Data Query 0.568256 sistema nervioso central 0.524289 verdaderos aceites 0.552975 bacterias mrsa 0.514519 Estados Unidos 0.774616 francés rene gattefosse 0.524782 libre uso 0.513229 National Association 0.51158 PDQ Aromaterapia 0.574967 página manejo 0.510182 ¿El tratamiento 0.520191 International Federation 0.512341 ¿Los beneficios 0.51034 juntos cam 0.50992 Holistic Aromatherapy 0.51402 Series Program 0.51015 medicina complementaria 0.964619	CLICK HERE
17292	National Cancer Institute	Html	es	Sangrado y moretones (trombocitopenia)	Información y consejos para controlar el sangrado y los moretones, los cuales son efectos secundarios del tratamiento del cáncer.	lip balm 0.762223		CLICK HERE